Outcome measures for airway clearance techniques in children with chronic obstructive lung diseases: a systematic review.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
17 Aug 2020
Historique:
received: 12 05 2020
accepted: 11 08 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 3 7 2021
Statut: epublish

Résumé

Airway clearance techniques (ACTs) are an important aspect of the treatment of children with chronic obstructive lung diseases. Unfortunately, a sound evidence base is lacking and airway clearance strategies are largely based on clinical expertise. One of the reasons for the limited evidence is the lack of appropriate outcome measures specifically related to the effectiveness of ACTs. This review discusses all outcome measures applied in previous research in the pediatric population to provide a baseline for future studies. A systematic literature search was performed in PubMed, Web of Science and EMBASE databases. Search terms included chronic obstructive lung diseases and ACTs. Studies were independently selected by the investigators according to the eligibility criteria. After screening, 49 articles remained for further analysis. Data are summarized according to the type of outcome measure. 48 (98%) studies performed pulmonary function tests, 19 (39%) assessed expectorated sputum, 10 (20%) parameters related to disease exacerbation, 8 (16%) oxygenation, 8 (16%) patient-reported outcomes, 5 (10%) exercise capacity and 5 (10%) applied imaging techniques. The synthesis of results showed a high discrepancy between studies due to differences in study design, population and the application of techniques. Since no 'gold standard' method could be identified, a combination of different outcome measures is recommended to gain a better understanding and to identify the potential effects of ACTs. An overview of important considerations has been provided to assist researchers in their choice of outcomes in future studies.

Sections du résumé

BACKGROUND BACKGROUND
Airway clearance techniques (ACTs) are an important aspect of the treatment of children with chronic obstructive lung diseases. Unfortunately, a sound evidence base is lacking and airway clearance strategies are largely based on clinical expertise. One of the reasons for the limited evidence is the lack of appropriate outcome measures specifically related to the effectiveness of ACTs. This review discusses all outcome measures applied in previous research in the pediatric population to provide a baseline for future studies.
DATA SOURCES METHODS
A systematic literature search was performed in PubMed, Web of Science and EMBASE databases. Search terms included chronic obstructive lung diseases and ACTs.
STUDY SELECTION METHODS
Studies were independently selected by the investigators according to the eligibility criteria. After screening, 49 articles remained for further analysis.
RESULTS AND CONCLUSIONS CONCLUSIONS
Data are summarized according to the type of outcome measure. 48 (98%) studies performed pulmonary function tests, 19 (39%) assessed expectorated sputum, 10 (20%) parameters related to disease exacerbation, 8 (16%) oxygenation, 8 (16%) patient-reported outcomes, 5 (10%) exercise capacity and 5 (10%) applied imaging techniques. The synthesis of results showed a high discrepancy between studies due to differences in study design, population and the application of techniques. Since no 'gold standard' method could be identified, a combination of different outcome measures is recommended to gain a better understanding and to identify the potential effects of ACTs. An overview of important considerations has been provided to assist researchers in their choice of outcomes in future studies.

Identifiants

pubmed: 32807200
doi: 10.1186/s12931-020-01484-z
pii: 10.1186/s12931-020-01484-z
pmc: PMC7433087
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

217

Références

Physiotherapy. 2012 Sep;98(3):250-5
pubmed: 22898583
Am J Dis Child. 1972 Mar;123(3):227-8
pubmed: 5026202
J Pediatr. 1997 Oct;131(4):570-4
pubmed: 9386661
Aust Paediatr J. 1987 Oct;23(5):283-4
pubmed: 3326574
Arch Dis Child. 2019 Jan;104(1):37-42
pubmed: 29794108
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S123-S128
pubmed: 28398090
J Cyst Fibros. 2011 Jun;10 Suppl 2:S82-5
pubmed: 21658648
Eur Respir J. 2013 Mar;41(3):507-22
pubmed: 23397305
Br J Dis Chest. 1988 Apr;82(2):138-48
pubmed: 3048363
Chest. 2004 Apr;125(4):1507-11
pubmed: 15078765
Eur Respir J. 1999 Jun;13(6):1477-86
pubmed: 10445628
Aust J Physiother. 2001;47(4):227-36
pubmed: 11722291
Ann Am Thorac Soc. 2013 Apr;10(2):S1-S11
pubmed: 23607855
J Pediatr. 1983 Oct;103(4):538-42
pubmed: 6620013
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
pubmed: 11240971
J Pediatr. 1988 Oct;113(4):632-6
pubmed: 3171787
Pediatr Pulmonol. 2007 Dec;42(12):1152-8
pubmed: 17968997
Arch Dis Child. 1979 Jul;54(7):542-4
pubmed: 384920
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
J Cyst Fibros. 2015 May;14(3):403-11
pubmed: 25443473
Thorax. 2013 Aug;68(8):746-51
pubmed: 23407019
Pediatr Pulmonol. 2012 Jan;47(1):68-75
pubmed: 21830316
Eur Respir J. 1998 Jul;12(1):143-7
pubmed: 9701429
Clin Pediatr (Phila). 1998 Jul;37(7):427-32
pubmed: 9675436
Respir Med. 2018 Apr;137:83-88
pubmed: 29605218
Thorax. 2013 Jul;68(7):643-51
pubmed: 23345574
Respiration. 1989;55(3):144-51
pubmed: 2682864
J Magn Reson Imaging. 2020 Nov;52(5):1306-1320
pubmed: 31846139
Am J Dis Child. 1984 Jun;138(6):574-6
pubmed: 6720644
Paediatr Respir Rev. 2002 Jun;3(2):110-4
pubmed: 12297056
Respir Care. 2014 Oct;59(10):1537-41
pubmed: 24847094
Thorax. 2017 Aug;72(8):760-762
pubmed: 28265032
Radiology. 2010 Apr;255(1):225-32
pubmed: 20308459
Acta Paediatr Scand. 1987 Jan;76(1):70-5
pubmed: 3565005
Hippokratia. 2007 Oct;11(4):202-4
pubmed: 19582195
Arch Dis Child. 1982 Aug;57(8):587-9
pubmed: 7114877
Pediatr Pulmonol. 1990;9(3):146-51
pubmed: 2277735
Respiration. 1980;40(1):53-6
pubmed: 7433776
Physiother Theory Pract. 2020 Nov;36(11):1245-1255
pubmed: 30669914
Pediatr Pulmonol. 2016 Dec;51(12):1362-1366
pubmed: 27273679
Am Rev Respir Dis. 1962 Jul;86:41-6
pubmed: 13885501
J Pediatr. 1994 Feb;124(2):250-4
pubmed: 8301432
Pediatrics. 1999 Mar;103(3):E32
pubmed: 10049988
Phys Ther. 2005 Dec;85(12):1278-89
pubmed: 16305267
J Cyst Fibros. 2013 Dec;12(6):567-74
pubmed: 23790270
Phys Ther. 1989 Aug;69(8):633-9
pubmed: 2748718
J Cyst Fibros. 2018 Jul;17(4):518-527
pubmed: 29805050
Respir Med. 2006 Feb;100(2):191-201
pubmed: 16412951
Chest. 1994 Jun;105(6):1789-93
pubmed: 8205878
Pediatr Cardiol. 2015 Dec;36(8):1553-64
pubmed: 26036349
Aust J Physiother. 2009;55(2):129-33
pubmed: 19463084
Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):841-5
pubmed: 18179758
Semin Respir Crit Care Med. 2015 Apr;36(2):251-66
pubmed: 25826592
Am J Med. 1985 Aug 9;79(2A):37-46
pubmed: 3895917
Respir Med. 2011 Jul;105(7):959-71
pubmed: 21356587
Acta Paediatr Scand. 1991 Jan;80(1):51-6
pubmed: 2028789
Pediatr Pulmonol. 2006 Jul;41(7):602-17
pubmed: 16703586
Pediatr Pulmonol. 2012 Jun;47(6):567-73
pubmed: 22170734
Med Devices (Auckl). 2014 Jul 08;7:231-9
pubmed: 25031547
Respir Care. 2012 Sep;57(9):1468-75
pubmed: 22348337
J Physiother. 2012;58(4):241-7
pubmed: 23177226
Pediatr Pulmonol. 2010 Nov;45(11):1064-9
pubmed: 20836133
Nat Rev Dis Primers. 2015 May 14;1:15010
pubmed: 27189798
Respir Care. 2007 Oct;52(10):1382-90; discussion 1390-1
pubmed: 17894905
Lung. 1992;170(6):323-30
pubmed: 1434782
Clin Respir J. 2017 Nov;11(6):703-712
pubmed: 26471240
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1143-1151
pubmed: 29560543
Pediatr Pulmonol. 1995 Jul;20(1):50-5
pubmed: 7478782
Respir Care. 2006 Oct;51(10):1154-61
pubmed: 17005061
Pediatr Pulmonol. 2004 Jan;37(1):71-5
pubmed: 14679493
Ann Am Thorac Soc. 2015 Jun;12(6):932-9
pubmed: 26075554
Paediatr Respir Rev. 2018 Jan;25:73-77
pubmed: 28408202
AJR Am J Roentgenol. 1980 Jun;134(6):1195-8
pubmed: 6770630
Am Rev Respir Dis. 1984 Jan;129(1):182-4
pubmed: 6703478
Am J Respir Crit Care Med. 2018 Mar 1;197(5):e1-e19
pubmed: 29493315
Cochrane Database Syst Rev. 2015 Dec 21;(12):CD001401
pubmed: 26688006
PLoS One. 2018 Jan 10;13(1):e0190894
pubmed: 29320566
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Chest. 1998 Oct;114(4):993-7
pubmed: 9792567
Acta Paediatr. 1997 Nov;86(11):1195-7
pubmed: 9401512
Chest. 1998 Jul;114(1):171-7
pubmed: 9674466
Thorax. 1991 Apr;46(4):252-6
pubmed: 2038733
J Pediatr. 2001 Jun;138(6):845-50
pubmed: 11391327
Eur Respir J. 1991 Feb;4(2):152-8
pubmed: 2044730
Pediatr Pulmonol. 1999 Oct;28(4):255-60
pubmed: 10497374
Eur Respir J. 2005 Jun;25(6):1057-60
pubmed: 15929962
Pediatr Pulmonol. 2014 Jun;49(6):611-6
pubmed: 24039238
Rev Paul Pediatr. 2016 Dec;34(4):408-411
pubmed: 27449074
Paediatr Respir Rev. 2019 Feb;29:23-24
pubmed: 30145147

Auteurs

Eline Lauwers (E)

Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2160 Wilrijk, Antwerp, Belgium. eline.lauwers@uantwerpen.be.
Infla-Med Research Consortium of Excellence, University of Antwerp, Antwerp, Belgium. eline.lauwers@uantwerpen.be.

Kris Ides (K)

Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2160 Wilrijk, Antwerp, Belgium.
Infla-Med Research Consortium of Excellence, University of Antwerp, Antwerp, Belgium.

Kim Van Hoorenbeeck (K)

Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2160 Wilrijk, Antwerp, Belgium.
Infla-Med Research Consortium of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatrics, Antwerp University Hospital, Edegem, Belgium.

Stijn Verhulst (S)

Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2160 Wilrijk, Antwerp, Belgium.
Infla-Med Research Consortium of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatrics, Antwerp University Hospital, Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH